Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

ClinicalTrials.gov ID: NCT00812058

Public ClinicalTrials.gov record NCT00812058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety, Tolerability and Efficacy of RG2417 (Uridine) in the Treatment of Bipolar I Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test a new drug, RG2417, to see how the drug affects symptoms of bipolar I depression and to make sure it is safe in humans.

Study identification

NCT ID
NCT00812058
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Repligen Corporation
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2008 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Dec 2010 (Actual)
Last update posted
Jan 17, 2011

2008 – 2010

United States locations

U.S. sites
36
U.S. states
25
U.S. cities
36
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
K&S Professional Research Services Little Rock Arkansas 72201 —
Affiliated Research Institute San Diego California 92108 —
Yale University New Haven Connecticut 06519 —
Behavioral Clinical Research North Miami Florida 33161 —
Clinical Neuroscience Solution, Inc. Orlando Florida 32806 —
University of South Florida College of Medicine Tampa Florida 33613 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Carman Research Smyrna Georgia 30080 —
Valle Vista Health System Greenwood Indiana 46143 —
Louisiana State University Health Sciences Center Shreveport Louisiana 71103 —
Johns Hopkins School of Medicine Baltimore Maryland 21205 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Mayo Clinic Department of Pscyhiatry & Psychology Rochester Minnesota 55905 —
Behavioral Medical Research of States Island Staten Island New York 10305 —
Unvieristy of North Carolina - Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
Richard H. Weisler, MD, PA and Associates Raleigh North Carolina 27609 —
University of Cincinnati Cincinnati Ohio 45267 —
Cleveland Clinic Cleveland Ohio 44195 —
Midwest Clinical Research Center Dayton Ohio 45408 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Oregon Center for Clinical Investigations, Inc. Portland Oregon 97210 —
Western Psychiatric Institute Clinic Pittsburgh Pennsylvania 15213 —
Lincoln Research Lincoln Rhode Island 02856 —
Ralph H. Johnson VA Medical Center Charleston South Carolina 29401 —
CNS Healthcare Memphis Tennessee 38119 —
Vanderbilt University School of Medicine Nashville Tennessee 37212 —
FutureSearch Trials of Austin Austin Texas 78756 —
FutureSearch Trials of Dallas Dallas Texas 75231 —
University of Texas, Houston Medical Center Houston Texas 77030 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
University of Utah Salt Lake City Utah 84132 —
University of Virginia Charlottesville Virginia 22903 —
Northwest Clinical Research Center Bellevue Washington 98004 —
Dean Foundation Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00812058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2011 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00812058 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →